BSC
Showing 1 - 25 of 2,916
MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Placebo for Oral Azacitidine
-
Buenos Aires, Argentina
- +1 more
Aug 1, 2022
Chronic Pain, Intractable Pain, Low Back Pain Trial in Greenville (Spinal Cord Stimulation)
Recruiting
- Chronic Pain
- +4 more
- Spinal Cord Stimulation
-
Greenville, South CarolinaPCPMG Clinical Research Unit, LLC
Aug 9, 2022
COVID-19, Infections, Morality Trial in Fuzhou (Medical observation, Supportive treatment (BSC), Intensive care management)
Recruiting
- COVID-19
- +3 more
- Medical observation
- +2 more
-
Fuzhou, Fujian, ChinaThe 900th Hospital of the Joint Logistic Support Force, PLA
Jan 7, 2023
Apnea, Sleep Trial in Shanghai (CPAP, BSC)
Completed
- Apnea, Sleep
- CPAP
- BSC
-
Shanghai, Shanghai, ChinaOtolaryngological Institute of Shanghai Jiao Tong University
Feb 13, 2022
Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)
Recruiting
- Mast Cell Activation Syndrome
- Masitinib 4.5 mg/kg/day
- +3 more
-
Weldon Spring, Missouri
- +1 more
Jul 18, 2022
G6PD Deficiency Trial in Reading (SD Biosensor STANDARD G6PD Test, Pointe Scientific Test Kit, HemoCue System)
Completed
- G6PD Deficiency
- SD Biosensor STANDARD G6PD Test
- +2 more
-
Reading, PennsylvaniaBSC corporation
Oct 15, 2021
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Platinum-sensitive Ovarian Cancer
- Relapsed Ovarian Cancer
- OSE2101
- Pembrolizumab 25 MG/ML [Keytruda]
-
Angers, France
- +27 more
Jul 25, 2022
Chronic Total Occlusion of Coronary Artery Trial (The guidewire successfully passed the CTO lesion)
Not yet recruiting
- Chronic Total Occlusion of Coronary Artery
- The guidewire successfully passed the CTO lesion
- (no location specified)
Jun 22, 2021
Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell
Recruiting
- Gastric Adenocarcinoma
- +2 more
- CT041 autologous CAR T-cell injection
- Physician's Choice(Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody)
-
Hefei, Anhui, China
- +9 more
Feb 13, 2022
Chronic Pain Trial in Worldwide (Spinal Cord Stimulation (SCS) System)
Completed
- Chronic Pain
- Spinal Cord Stimulation (SCS) System
-
Muenchen, Germany
- +4 more
Dec 10, 2020
Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))
Active, not recruiting
- Thalassemia
- Luspatercept
- +2 more
-
Los Angeles, California
- +16 more
Aug 16, 2022
Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Covid19 Trial in Mumbai, New Delhi (Itolizumab IV infusion, Best
Completed
- Acute Respiratory Distress Syndrome
- +2 more
- Itolizumab IV infusion
- Best supportive care (BSC)
-
Mumbai, India
- +3 more
Jun 10, 2021
Parkinson Disease Trial in Grenoble, Wuerzburg, Amsterdam (BSC Deep Brain Stimulation System with Directional Lead)
Completed
- Parkinson Disease
- BSC Deep Brain Stimulation System with Directional Lead
-
Grenoble, France
- +2 more
Nov 17, 2020
Rota China Registry
Recruiting
- Coronary Artery Disease
- Rotational Atherectomy
-
Beijing, Beijing, China
- +16 more
Sep 2, 2021
Colorectal Cancer Trial in China (fruquintinib, )
Peripheral Vascular Diseases Trial in Worldwide (Any eligible commercially available Boston Scientific Corporation (BSC)
Recruiting
- Peripheral Vascular Diseases
- Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
-
Jonesboro, Arkansas
- +63 more
Jan 17, 2023
Chronic Pain Trial in United States (Non Boston Scientific SCS Trial Therapy, BSC approved SCS Trial Therapy w/ OMG)
Completed
- Chronic Pain
- Non Boston Scientific SCS Trial Therapy
- BSC approved SCS Trial Therapy w/ OMG
-
Phoenix, Arizona
- +12 more
Nov 10, 2020
Nasopharyngeal Carcinoma Trial in Guangzhou (capecitabine, Best supportive care (BSC))
Completed
- Nasopharyngeal Carcinoma
- capecitabine
- Best supportive care (BSC)
-
Guangzhou, Guangdong, ChinaSunYat-senU
Jul 30, 2020
Anemia Trial in Worldwide (biological, drug, other)
Recruiting
- Anemia
- Luspatercept
- +2 more
-
Halifax, Nova Scotia, Canada
- +11 more
Jan 3, 2023
Refractory Metastatic Gastric Cancer Trial in Worldwide (TAS-102, Placebo)
Completed
- Refractory Metastatic Gastric Cancer
- TAS-102
- Placebo
-
Gilbert, Arizona
- +138 more
Aug 19, 2021
Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)
Active, not recruiting
- Carcinoma, Hepatocellular
- pembrolizumab
- +2 more
-
Hefei, Anhui, China
- +40 more
Mar 3, 2022